HIV

Latest News

Lenacapavir HIV PrEP: Not an AIDS Vaccine, but Vaccine Adjacent
Lenacapavir HIV PrEP: Not an AIDS Vaccine, but Vaccine Adjacent

June 19th 2025

Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be available to the people who would benefit most from HIV PrEP?

FDA Approves Lenacapavir as the First Twice-Yearly PrEP for HIV Prevention
FDA Approves Lenacapavir as the First Twice-Yearly PrEP for HIV Prevention

June 18th 2025

Specialty Pharmacy Model Improves HIV Treatment Outcomes in Young Patients
Specialty Pharmacy Model Improves HIV Treatment Outcomes in Young Patients

June 13th 2025

Trump Budget Axes CDC HIV Prevention, Shifts Care, Experts Warn of Risks
Trump Budget Axes CDC HIV Prevention, Shifts Care, Experts Warn of Risks

June 10th 2025

depiction of monoclonal antibodies against HIV | image credit: @和正 住原 stock.adobe.com
Phase 1 Results for a Longer-Lasting Monoclonal Antibody Against HIV-1 Are Positive, Researchers Report

June 4th 2025

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.